Upregulation of lncRNA FOXD2-AS1 expression could promote the progression of HCC by causing epigenetic silencing of DKK1 and activating the Wnt/β-catenin signaling pathway [46]. This evidence concerns the gene FOXD2 and hepatocellular carcinoma.